Association Between Different Parameters of Adipose Distribution and Transient Elastography-Assessed Hepatic Steatosis in American Adults with Diabetes, Prediabetes and Normal Glucose Tolerance

References

• Scully T. Diabetes in numbers. Nature. 2012;485(7398):S2–3. doi:10.1038/485S2a
   PubMedGoogle Scholar
• Singh GK, Siahpush M, Altekruse SF. Time trends in liver cancer mortality, incidence, and risk factors by unemployment level and race/ethnicity, United States, 1969–2011. J Commun Health. 2013;38(5):926–940. doi:10.1007/s10900-013-9703-z
   PubMed Web of Science ®Google Scholar
• Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999–2016: observational study. BMJ. 2018;362:k2817. doi:10.1136/bmj.k2817
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004;126(2):460–468. doi:10.1053/j.gastro.2003.10.065
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Rodella S, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care. 2007;30(8):2119–2121. doi:10.2337/dc07-0349
   PubMed Web of Science ®Google Scholar
• Thomas EL, Fitzpatrick JA, Malik SJ, Taylor-Robinson SD, Bell JD. Whole body fat: content and distribution. Prog Nucl Magn Reson Spectrosc. 2013;73:56–80. doi:10.1016/j.pnmrs.2013.04.001
   PubMed Web of Science ®Google Scholar
• Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359–404. doi:10.1152/physrev.00033.2011
   PubMed Web of Science ®Google Scholar
• van der Poorten D, Milner KL, Hui J, et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008;48(2):449–457. doi:10.1002/hep.22350
   PubMed Web of Science ®Google Scholar
• Park BJ, Kim YJ, Kim DH, et al. Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J Gastroenterol Hepatol. 2008;23(6):900–907. doi:10.1111/j.1440-1746.2007.05212.x
   PubMed Web of Science ®Google Scholar
• Yu SJ, Kim W, Kim D, et al. Visceral obesity predicts significant fibrosis in patients with nonalcoholic fatty liver disease. Medicine. 2015;94(48):e2159. doi:10.1097/MD.0000000000002159
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13–S28. doi:10.2337/dc19-S002
   PubMed Web of Science ®Google Scholar
• Shah AD, Kandula NR, Lin F, et al. Less favorable body composition and adipokines in South Asians compared with other US ethnic groups: results from the MASALA and Mesa studies. Int J Obes. 2016;40(4):639–645. doi:10.1038/ijo.2015.219
   Web of Science ®Google Scholar
• Alenaini W, Parkinson J, McCarthy JP, et al. Ethnic differences in body fat deposition and liver fat content in two UK-based cohorts. Obesity. 2020;28:2142–2152. doi:10.1002/oby.22948
   PubMed Web of Science ®Google Scholar
• Zhang E, Wartelle-Bladou C, Lepanto L, Lachaine J, Cloutier G, Tang A. Cost-utility analysis of nonalcoholic steatohepatitis screening. Eur Radiol. 2015;25(11):3282–3294. doi:10.1007/s00330-015-3731-2
   PubMed Web of Science ®Google Scholar
• Castéra L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128(2):343–350. doi:10.1053/j.gastro.2004.11.018
   PubMed Web of Science ®Google Scholar
• Barr RG, Ferraioli G, Palmeri ML, et al. Elastography assessment of liver fibrosis: society of radiologists in ultrasound consensus conference statement. Radiology. 2015;276(3):845–861. doi:10.1148/radiol.2015150619
   PubMed Web of Science ®Google Scholar
• Sirli R, Sporea I. Controlled attenuation parameter for quantification of steatosis: which cut-offs to use. Can J Gastroenterol Hepatol. 2021;2021:6662760. doi:10.1155/2021/6662760
   PubMed Web of Science ®Google Scholar
• Bouchi R, Nakano Y, Ohara N, et al. Clinical relevance of dual-energy X-ray absorptiometry (DXA) as a simultaneous evaluation of fatty liver disease and atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2016;15:64. doi:10.1186/s12933-016-0384-7
   PubMed Web of Science ®Google Scholar
• Janochova K, Haluzik M, Buzga M. Visceral fat and insulin resistance - what we know. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019;163(1):19–27. doi:10.5507/bp.2018.062
   PubMed Web of Science ®Google Scholar
• Pahlavani M, Ramalho T, Koboziev I, et al. Adipose tissue inflammation in insulin resistance: review of mechanisms mediating anti-inflammatory effects of omega-3 polyunsaturated fatty acids. J Investig Med. 2017;65(7):1021–1027. doi:10.1136/jim-2017-000535
   PubMed Web of Science ®Google Scholar
• Reddy KJ, Singh M, Bangit JR, Batsell RR. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review. J Cardiovasc Med. 2010;11(9):633–647. doi:10.2459/JCM.0b013e328333645a
   Google Scholar
• Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120(5):1183–1192. doi:10.1053/gast.2001.23256
   PubMed Web of Science ®Google Scholar
• Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 2002;35(2):373–379. doi:10.1053/jhep.2002.30692
   PubMed Web of Science ®Google Scholar
• Willner IR, Waters B, Patil SR, Reuben A, Morelli J, Riely CA. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol. 2001;96(10):2957–2961. doi:10.1111/j.1572-0241.2001.04667.x
   PubMed Web of Science ®Google Scholar
• Pagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology. 2002;35(2):367–372. doi:10.1053/jhep.2002.30690
   PubMed Web of Science ®Google Scholar
• Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005;143(10):722–728. doi:10.7326/0003-4819-143-10-200511150-00009
   PubMed Web of Science ®Google Scholar
• Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev. 1994;74(4):761–811. doi:10.1152/physrev.1994.74.4.761
   PubMed Web of Science ®Google Scholar
• Folsom AR, Kushi LH, Anderson KE, et al. Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women’s Health Study. Arch Intern Med. 2000;160(14):2117–2128. doi:10.1001/archinte.160.14.2117
   PubMedGoogle Scholar
• Alferink L, Trajanoska K, Erler NS, et al. Nonalcoholic fatty liver disease in the Rotterdam study: about muscle mass, sarcopenia, fat mass, and fat distribution. J Bone Miner Res. 2019;34(7):1254–1263. doi:10.1002/jbmr.3713
   PubMed Web of Science ®Google Scholar
• Fang D, Tang W, Zhao X, Sun H, Gu T, Bi Y. Gender differences in the association of body composition and biopsy-proved nonalcoholic steatohepatitis. Hepatol Int. 2022;16(2):337–347. doi:10.1007/s12072-021-10265-9
   PubMed Web of Science ®Google Scholar
• Kaul S, Rothney MP, Peters DM, et al. Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity. 2012;20(6):1313–1318. doi:10.1038/oby.2011.393
   PubMed Web of Science ®Google Scholar
• Murphy J, Bacon SL, Morais JA, Tsoukas MA, Santosa S. Intra-abdominal adipose tissue quantification by alternative versus reference methods: a systematic review and meta-analysis. Obesity. 2019;27(7):1115–1122. doi:10.1002/oby.22494
   PubMed Web of Science ®Google Scholar